The LimFlow® TADV System: Taking CLTI Patients From “No Option” to “Next Option”
Purpose-built innovation, durable evidence, and the imperative to treat earlier.
With Daniel Clair, MD; Mehdi H. Shishehbor, DO, MPH, PhD; Steven Abramowitz, MD; Michael C. Siah, MD; Yana Etkin, MD; and Miguel Manzur, MD
